A qualified provider integrates medical history, lab markers, andif availablegenetic predisposition data to personalize selection and dosing
WEDNESDAY, April 24, 2024 (HealthDay News) -- Glucagon-like peptide 1 (GLP1) receptor agonist use does not appear to be associated with an increased risk for thyroid cancer, according to a study published online April 10 in The BMJ
However, not all supplements are created equal, and many people feel frustrated when they don't see the results they expect from standard pills
R.TustinN
Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations